The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial
The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial
复制标题
DOI：
10.1111/nmo.12663
复制
发表时间：
2015-11
影响因子：
3.5
通讯作者：
R. Hobson;A. Farmer;O. Dewit;M. O'Donnell;K. Hacquoil;D. Robertson;M. Barton;G. Dukes
中科院分区：
文献类型：
--
作者：
R. Hobson;A. Farmer;O. Dewit;M. O'Donnell;K. Hacquoil;D. Robertson;M. Barton;G. Dukes
一部分前肠动力障碍患者对标准干预措施无反应。胃动素激动剂可能是有益的，在这一组。我们的目的是确定一种新的胃动素激动剂，对健康志愿者胃肠道生理的影响。
A proportion of patients with foregut dysmotility fail to respond to standard interventions. Motilin agonists may be beneficial in this group. We aimed to determine the effect of camicinal, a novel motilin agonist, on gastrointestinal physiology in healthy volunteers.